Fort Lauderdale, FL
RECO Immersive / Locations / Fort Lauderdale

Psychiatric medication management for Fort Lauderdale — residential-level optimization, 40 minutes away.

A specialist outpatient program for clients in Fort Lauderdale. PHP, IOP, in-house psychiatry, sober-living network, family programming. Same admissions team, 24/7.

Start the conversation Or call directly — (561) 464-4077
26 mi from Fort Lauderdale
40 min average drive
24/7 admissions line
Why RECO Immersive from Fort Lauderdale

Local options exist. This is the clinical specialist.

From Las Olas or Victoria Park, RECO Immersive is 40 minutes up I-95 — a 26-mile drive that keeps family involvement possible while removing the daily variables that made the outpatient regimen fail. Psychiatry is run continuously rather than in weekly slots: observed adherence at every medication pass, a medically driven lab cadence, and coordination with rTMS or ketamine when interventional treatment is part of the plan. Clients leave with a written medication plan that transfers cleanly to their Broward County outpatient prescriber.

For adults in Fort Lauderdale whose psychiatric medications have stopped producing results despite years of outpatient adjustment, RECO Immersive sits 26 miles north on I-95 — roughly a 40-minute drive from Las Olas, Victoria Park, Coral Ridge, Rio Vista, or Wilton Manors. That distance is deliberate. Close enough that family can stay involved and aftercare can continue at home; far enough that residential-level pharmacology can proceed without the daily variables — work stress, disordered sleep, alcohol, quiet nonadherence — that caused the outpatient regimen to fail in the first place.

Why residential medication management differs from outpatient adjustment

Psychiatry inside RECO Immersive is not a weekly appointment squeezed between groups. It is a continuous clinical presence. The prescribing psychiatrist reviews response data collected during structured programming, adjusts based on observed behavior rather than the client’s recollection at the next visit, and can move regimen decisions in days rather than months. That compressed timeline is what residential care actually buys in pharmacologic terms: a client who has cycled through three SSRIs, an SNRI, and an augmentation trial over four years can complete a rational cross-taper and stabilize on a working regimen inside a single 30-to-45-day stay.

Standardized instruments drive the titration. PHQ-9 for depressive symptoms, GAD-7 for anxiety, YBOCS for OCD, ASRS for adult ADHD, and the CIWA and COWS protocols where withdrawal management is part of the plan — each is re-administered on a scheduled cadence so that psychiatric medication management proceeds against measured change rather than clinical impression alone. The result is a decision trail the outpatient prescriber inherits — not a black box handoff.

What observed adherence and daily monitoring change

In outpatient care, whether the client actually takes the medication as prescribed is functionally a matter of trust — self-report at follow-up, occasional pill counts, a level draw for the agents that warrant it. In residential care, adherence is observed at each medication pass. For medications with narrow therapeutic windows — lithium, valproate, lamotrigine during titration — that observation is what makes dose optimization possible. A lithium trough drawn against a known-adherent baseline is interpretable data. The same trough drawn against uncertain outpatient adherence is a guess.

Side effects also surface immediately. A client who develops akathisia on aripiprazole is not going home and quietly discontinuing; the nursing team documents the restlessness, the psychiatrist adds propranolol or transitions to a lower-akathisia agent, and the trial does not fail for a preventable reason. The same principle applies to sedation on quetiapine, metabolic shift on olanzapine, and the sexual side effects on SSRIs like sertraline that would ordinarily drive silent nonadherence between outpatient visits.

Comprehensive lab monitoring during the residential stay

Every admission begins with a baseline panel — CBC, CMP, TSH, B12 and folate, vitamin D, lipid panel, HbA1c, urine drug screen, urine pregnancy where indicated, and hepatic enzymes when the plan includes hepatically metabolized agents. From that baseline, monitoring is medically driven rather than scheduling-driven. Lithium and valproate levels are drawn weekly during titration and again after any dose change; metabolic panels are repeated at admission and discharge for clients on second-generation antipsychotics; an EKG is obtained when QTc-prolonging agents, cardiovascular history, or age warrant it.

That cadence is what allows the psychiatry team to run trials outpatient care cannot reasonably attempt on the same timeline — a structured lithium initiation in treatment-resistant bipolar depression, a clozapine trial in a client who has failed multiple antipsychotics with documented registry monitoring, or a rational MAOI trial in refractory depression that requires a supervised washout period.

Coordination with concurrent interventional treatment

Many residential clients are also candidates for interventional psychiatry at RECO Health — rTMS delivered at 3000 pulses per session at 120% of motor threshold over a six-week course, or IV ketamine and intranasal esketamine for treatment-resistant depression. When those tracks run concurrently with residential pharmacology, the same psychiatry team runs both rather than negotiating across independent prescribers. That coordination matters concretely: oral antidepressant adherence during the TMS course is protected, benzodiazepines are minimized because they attenuate rTMS response, and the regimen is adjusted around ketamine dosing so interventional gains are consolidated rather than blunted.

The same integration applies to co-occurring substance use. A client entering with active alcohol dependence is stabilized under a CIWA-protocol taper before pharmacologic work on the underlying mood disorder resumes. A client with opioid use disorder is induced onto buprenorphine or transitioned to extended-release naltrexone, with COWS scores guiding timing. Anti-craving pharmacology and psychiatric pharmacology are managed as one integrated plan, not two independent workstreams.

What the first psychiatric evaluation covers

The intake evaluation is longer and more granular than a typical outpatient visit. It covers full psychiatric and medical history, every prior medication trial with the concrete reason for discontinuation, family psychiatric history, substance use history, and where relevant an ASAM Criteria assessment across the six dimensions. Trauma history is taken carefully; its formulation informs whether trauma-focused work — EMDR, prolonged exposure, or Cognitive Processing Therapy — will run concurrently with the pharmacologic phase or sequentially after stabilization.

From that evaluation the psychiatrist and treatment team assemble an integrated plan: the medication regimen, the therapy modalities (CBT, DBT skills, ACT, and MI where readiness-to-change work is indicated), the interventional track if warranted, and explicit discharge criteria written against symptom-scale thresholds. The plan is revisited each week in treatment team and adjusted against measured symptom change rather than clinical impression.

The medication plan the client leaves with

Discharge from RECO Immersive is a handoff, not an endpoint. Every client leaves with a written plan: the current regimen and its clinical rationale, the next-step contingencies if specific targets are not met over the following 30 to 90 days, the monitoring schedule for any labs the outpatient prescriber will need to draw, and a plain-language summary the client can reference themselves.

The plan transfers cleanly to the RECO Health outpatient team for clients who step down within the system, or to a home-community prescriber in Broward County for clients returning to Fort Lauderdale. That handoff clarity is what allows the residential pharmacology gains to hold. A client who leaves knowing what they are on, why, and what the next visit will focus on does not silently discontinue.

Insurance and admissions from Fort Lauderdale

RECO Immersive works with most major commercial insurers — Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans. Benefits verification is typically completed the same business day for Fort Lauderdale referrals, and clinical intake can begin immediately after. Same-day admission from Las Olas, Victoria Park, Wilton Manors, or Coral Ridge is routine when medical necessity criteria are met, and transportation to the Delray Beach campus is arranged through admissions when a family drop-off is not practical.

Serving residents of: Las Olas, Victoria Park, Coral Ridge, Rio Vista, Wilton Manors.

Common questions

From Fort Lauderdale callers, most asked.

Does RECO Immersive take my insurance if I'm coming from Fort Lauderdale?
RECO Immersive works with most major commercial plans — Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS — for residential mental health care. Verification of benefits for Fort Lauderdale referrals is typically completed within the same business day, and admissions will walk through the deductible, coinsurance, and expected out-of-pocket cost before intake begins. If a plan sits out of network, the admissions team can provide a good-faith estimate and discuss single-case agreements where clinical criteria warrant. Coverage generally hinges on documented medical necessity rather than diagnosis alone, so the intake psychiatric evaluation drives what an insurer will authorize.
How long does a residential stay for medication management usually last?
Length of stay at RECO Immersive typically runs 30 to 45 days, though the medically appropriate window depends on the pharmacology work involved. A straightforward SSRI-to-SNRI cross-taper with augmentation stabilizes faster than a structured lithium initiation, a clozapine trial, or an MAOI transition, each of which carries washout and monitoring requirements that lengthen the stay. Concurrent substance-use stabilization — a CIWA-protocol alcohol taper or a buprenorphine induction guided by COWS — is folded into the same admission rather than extending it. Treatment team reviews progress weekly and sets discharge criteria against measured symptom change on PHQ-9, GAD-7, or the diagnosis-specific scale in use.
What happens on the first day at RECO Immersive?
Admission day begins with a nursing assessment, baseline vitals, and a full lab panel — CBC, CMP, TSH, B12 and folate, vitamin D, lipid panel, HbA1c, urine drug screen, and urine pregnancy where indicated. The intake psychiatric evaluation follows and covers full psychiatric history, every prior medication trial with the reason for discontinuation, medical and family history, substance use history, and ASAM Criteria dimensions where relevant. Trauma history is taken carefully because it informs whether EMDR, prolonged exposure, or CPT will run concurrently with the pharmacologic phase or sequentially after stabilization. By evening, the initial medication regimen and monitoring plan are documented and the client meets the primary therapist assigned to the case.
Can my regimen be restructured while I'm there, or is that outpatient work?
Regimen restructuring is precisely what residential-level medication management is designed to accomplish. The compressed timeline — observed adherence at every medication pass, weekly standardized scales, and lab monitoring on a medically driven cadence — allows the psychiatrist to complete cross-tapers, initiate agents with strict monitoring requirements like lithium or clozapine, and pursue augmentation strategies that would take months to attempt safely in outpatient care. Trials that failed previously because of side effects, adherence gaps, or slow titration can be revisited under controlled conditions. Interventional options — rTMS at 3000 pulses per session at 120% of motor threshold, IV ketamine, or intranasal esketamine — are coordinated inside the same plan when indicated.
How do I get to RECO Immersive from Fort Lauderdale?
RECO Immersive is 26 miles north of Fort Lauderdale in Delray Beach — about 40 minutes on I-95 in typical traffic. From Las Olas, Victoria Park, Coral Ridge, Rio Vista, or Wilton Manors, admissions can coordinate transportation to campus on the day of admission if a family drop-off is not practical. Fort Lauderdale-Hollywood International Airport is roughly 35 minutes from campus for family members traveling in from out of state to accompany a loved one. The drive is short enough that family involvement — Family Program weekends and scheduled family therapy sessions — remains realistic throughout the residential stay.
How is family involved without compromising the client's privacy?
RECO Immersive runs a structured Family Program with dedicated weekend sessions, psychoeducation for families of clients with depression, bipolar disorder, PTSD, or co-occurring substance use, and family therapy scheduled into the treatment plan when the clinical formulation supports it. Every family contact is governed by the client's written consent under HIPAA and, where applicable, 42 CFR Part 2 for substance-use records. What information is shared, with whom, and in what form is decided with the client rather than around them. Families in Broward County who cannot make the 40-minute drive every weekend often participate via secure video for structured sessions between in-person visits.
Start admissions

Confidential. No commitment.

Tell us a little and a real human from admissions will call you back. We verify insurance benefits within minutes and tell you honestly whether RECO Immersive is the right fit — including if we should refer you elsewhere.

Carriers commonly used in Fort Lauderdale:
Florida Blue Aetna Cigna UnitedHealthcare Humana BCBS
Take the next step

When you’re ready, we’re here.

(561) 464-4077
Start AdmissionsSend a Message